Healthcare in Focus: A Major Event in Henan — Don’t Miss It, Tomorrow Awaits!

Spring tides surge, and all things are renewed.

With the "Health First Development Strategy" included in the 2025 Government Work Report, the medical and health industry is ushering in unprecedented development opportunities.

On the afternoon of March 20, 2025, the “2025 Henan Medical and Health Industry High-Quality Development and Supply Chain Finance Summit” will officially open in Zhengzhou. This summit, gathering forces from government, enterprises, medical institutions, research organizations, and financial institutions, will directly address industry pain points. Under the theme of "Linking Healthcare, Empowering the Future", the event aims to inject strong momentum into Henan’s transformation from a "province with a large pharmaceutical sector" to a "province with a strong pharmaceutical industry."

According to reports from Dahe Caifangli journalists at the summit’s organizing committee, the guidance units of the event include:

• Henan Provincial Department of Industry and Information Technology

• Henan Provincial Health Commission

• Henan Daily Press Group

• Henan Provincial Medical Security Bureau

• Henan Provincial Drug Administration

The organizing units are:

• Financial Media Center of Henan Daily Newspaper

• Henan Modern Pharmaceutical Industry Alliance

• Zhengzhou Medical Device Industry Association

The undertaking units include:

• Dahe Caifangli

• Caifangli Factoring

• Caifangli Supply Chain

At the event, government authorities will share the latest policy updates.

The summit will also bring together leading experts and industry leaders to explore the deep integration of healthcare and supply chain finance.

Ms. Yao Feng’e, Head of the Healthcare Industry at KPMG China, will provide an in-depth analysis of China’s healthcare system development trends during the 15th Five-Year Plan period.

Mr. Geng Hongwu, Deputy Director of the Tsinghua University Healthcare Research Center, will discuss the new opportunities brought by healthcare reforms.

Mr. Chi Xiaowei, Deputy Secretary-General of the China Pharmaceutical Enterprise Management Association, will analyze the industry’s development trends from the perspective of pharmaceutical industry economic operations.

In addition, during the roundtable discussion themed "Medical Supply Chain: Integration and Empowerment", executives from leading companies will jointly explore innovative paths for financial and industrial collaboration, offering breakthrough ideas to address financing challenges faced by small and medium-sized enterprises.

Notably, the summit will establish three major signing matrices:

• Production and sales cooperation

• Industry-finance collaboration

• Industry-academia-research synergy

This will promote efficient interaction across the entire industrial chain.

There will be several production and sales cooperation agreements, including:

• Zhongjing Wanxi Pharmaceutical and Jiuzhou Tong

• Hualan Biological and Sinopharm Tianxing Puxin

• Philips (China) and Caifangli Supply Chain

These partnerships will bridge the "last mile" between production and market demand.

Meanwhile, financial institutions such as China Minsheng Bank and Shanghai Pudong Development Bank will sign credit agreements with pharmaceutical companies.
Caifangli Factoring will also enter into a financing agreement with Huaren Medical Supply Chain, enhancing access to capital for small and medium-sized enterprises and alleviating the common problem of "easy to win bids, hard to collect payments."

Additionally, the Henan Academy of Medical Sciences will sign cooperation agreements with Boshiman and Kangfute Medical.
Zhengzhou Central Hospital will form a strategic partnership with Antu Bio.
Caifangli Digital Technology’s “Yi Cai Tong” platform will sign a strategic agreement with the Zhengzhou Medical Device Industry Association, promoting the commercialization of scientific research results through multi-party collaboration.

At the same time, the summit will serve as a “debut stage” for Henan’s achievements in the medical and health sector.

The “White Paper on the Development of Henan’s Pharmaceutical Industry (2025)” will be released for the first time, offering an in-depth analysis of policy trends in healthcare, health insurance, and pharmaceuticals, and providing a comprehensive roadmap for industry development.

At the event, Dahe Caifangli will launch its "Medi-Business Finance 2.0" financial tool, effectively supporting the financing needs of small and medium-sized enterprises.

In addition, leaders from Xiangcheng City will showcase the potential of the local medical and health industry, promoting coordinated development between regional resources and provincial strategies.

The summit will not only feature innovation showcases from leading enterprises such as Zhongjing Wanxi, Hualan Biological, and Lingrui Pharmaceutical, but also attract participation from national and international giants like Philips and Jiuzhou Tong.

Old friends and new allies will gather in Zhengzhou to witness the "golden moments" of Henan’s medical and health industry development.

From policy guidance to financial empowerment, from industry-finance collaboration to intelligent transformation, the summit will provide a powerful collaborative push for the high-quality development of Henan’s medical and health industry.

March 20, Zhengzhou.
Let’s link healthcare, empower the future, and forge a new chapter together.